Logo image
Safety and efficacy of gene transfer for Leber's congenital amaurosis
Journal article   Open access   Peer reviewed

Safety and efficacy of gene transfer for Leber's congenital amaurosis

Albert M Maguire, Francesca Simonelli, Eric A Pierce, Edward N Pugh Jr, Federico Mingozzi, Jeannette Bennicelli, Sandro Banfi, Kathleen A Marshall, Francesco Testa, Enrico M Surace, …
The New England journal of medicine, Vol.358(21), pp.2240-2248
05/22/2008
DOI: 10.1056/NEJMoa0802315
PMCID: PMC2829748
PMID: 18441370
url
https://doi.org/10.1056/NEJMoa0802315View
Published (Version of record) Open Access

Abstract

Leber's congenital amaurosis (LCA) is a group of inherited blinding diseases with onset during childhood. One form of the disease, LCA2, is caused by mutations in the retinal pigment epithelium-specific 65-kDa protein gene (RPE65). We investigated the safety of subretinal delivery of a recombinant adeno-associated virus (AAV) carrying RPE65 complementary DNA (cDNA) (ClinicalTrials.gov number, NCT00516477 [ClinicalTrials.gov]). Three patients with LCA2 had an acceptable local and systemic adverse-event profile after delivery of AAV2.hRPE65v2. Each patient had a modest improvement in measures of retinal function on subjective tests of visual acuity. In one patient, an asymptomatic macular hole developed, and although the occurrence was considered to be an adverse event, the patient had some return of retinal function. Although the follow-up was very short and normal vision was not achieved, this study provides the basis for further gene therapy studies in patients with LCA.
Mutation Dependovirus - genetics Gene Transfer Techniques Genetic Therapy Promoter Regions, Genetic Retinal Degeneration - genetics Humans Blindness - pathology Visual Acuity Blindness - genetics Carrier Proteins - genetics Injections Reflex, Pupillary Retinal Degeneration - therapy Adult Blindness - congenital Blindness - therapy Eye Proteins - genetics Retinal Degeneration - congenital Genetic Vectors Retinal Degeneration - pathology Retina - pathology cis-trans-Isomerases DNA, Complementary

Details

Metrics

Logo image